15 patients with myeloproliferative diseases and thrombocythaemia ( 7 polycythaemia vera , 5 essential thrombocythaemia , 3 chronic myelogenous leukaemia ) were assigned to a therapy with recombinant interferon ( recombinant ifn-alpha-2c ) in a prospective , controlled trial .
C0836924
thrombocythaemia
C0040028
essential thrombocythaemia